Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Société des Produits Nestlé S.A. currently manages 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This single action is assigned to 1 distinct examiner, KARUNASENA, ENUSHA, and is located within 1 distinct art unit. This concentration indicates a highly focused prosecution footprint for the company's current filings.
KARUNASENA, ENUSHA is the busiest examiner for the portfolio, holding 1 busiest examiner pending office action. This figure matches the total of 1 pending office action reported for the company. Because there is only 1 distinct examiner and 1 distinct art unit, the interaction with the patent office is streamlined under a single point of review.
The presence of 1 pending office action within the Biotechnology & Pharmaceuticals sector suggests a specific technical focus. With 1 distinct examiner and 1 distinct art unit involved, the company faces a singular administrative path. This 1 busiest examiner pending action managed by KARUNASENA, ENUSHA defines the current scope of prosecution for Société des Produits Nestlé S.A.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KARUNASENA, ENUSHA | 1 | 25.0% | +100.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18558956 | COMPOSITIONS AND METHODS USING AT LEAST ONE OF INOSITOL, ERYTHRITOL OR SORBITOL TO ENHANCE GROWTH OF FAECALIBACTERIUM PRAUSNITZII | KARUNASENA, ENUSHA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18558956 | COMPOSITIONS AND METHODS USING AT LEAST ONE OF INOSITOL, ERYTHRITOL OR SORBITOL TO ENHANCE GROWTH OF FAECALIBACTERIUM PRAUSNITZII | KARUNASENA, ENUSHA | — |
| Art Unit | Apps |
|---|---|
| 1653 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18558956 | COMPOSITIONS AND METHODS USING AT LEAST ONE OF INOSITOL, ERYTHRITOL OR SORBITOL TO ENHANCE GROWTH OF FAECALIBACTERIUM PRAUSNITZII | KARUNASENA, ENUSHA | 1653 | §101§102 | Non-Final OA | — | Pending | Nov 03, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialSociété des Produits Nestlé S.A. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Enusha Karunasena has the most, with 1 of Société des Produits Nestlé S.A.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
